Nishan M Desilva's Net Worth
-$16.2 Thousand
Who is Nishan M Desilva?
Nishan M Desilva does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cartesian Therapeutics, Inc., ALLOS THERAPEUTICS INC, LIGAND PHARMACEUTICALS INC, and Talon Therapeutics, Inc..
SEC CIK
Nishan M Desilva's CIK is 0001492386
Past Insider Trading and Trends
2011 was Nishan M Desilva's most active year for acquiring shares with 3 total transactions. Nishan M Desilva's most active month to acquire stocks was the month of December. 2023 was Nishan M Desilva's most active year for disposing of shares, totalling 3 transactions. Nishan M Desilva's most active month to dispose stocks was the month of October. 2011 saw Nishan M Desilva paying a total of $41,200.00 for 90,000 shares, this is the most they've acquired in one year. In 2023 Nishan M Desilva cashed out on 195,000 shares for a total of $69,750.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cartesian Therapeutics, Inc. (RNAC) Snapshot price: $0.64165
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,542.86% | 178K |
—
|
—
| 185K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 7K |
$2.96 | $20,722.80 | 7K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALLOS THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 35K |
—
|
—
| 35K |
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $75.31
VP, Corporate Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Talon Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||